Thrombocytopenia 4
|
0.610 |
CausalMutation
|
disease |
CLINVAR |
THC4 is an autosomal dominant mild thrombocytopenia described in only one large family from New Zealand and due to a mutation (G41S) of the somatic isoform of the cytochrome c (CYCS) gene.
|
24326104 |
2014 |
Thrombocytopenia 4
|
0.610 |
GeneticVariation
|
disease |
BEFREE |
THC4 is an autosomal dominant mild thrombocytopenia described in only one large family from New Zealand and due to a mutation (G41S) of the somatic isoform of the cytochrome c (CYCS) gene.
|
24326104 |
2014 |
Thrombocytopenia 4
|
0.610 |
CausalMutation
|
disease |
CLINVAR |
A mutation of human cytochrome c enhances the intrinsic apoptotic pathway but causes only thrombocytopenia.
|
18345000 |
2008 |
Thrombocytopenia 4
|
0.610 |
GeneticVariation
|
disease |
UNIPROT |
A mutation of human cytochrome c enhances the intrinsic apoptotic pathway but causes only thrombocytopenia.
|
18345000 |
2008 |
Thrombocytopenia 4
|
0.610 |
Biomarker
|
disease |
CTD_human |
|
|
|
Thrombocytopenia
|
0.440 |
GeneticVariation
|
phenotype |
BEFREE |
In the last 5 years, nine new genes whose mutations are responsible for thrombocytopenia have been identified, and this also led to the recognition of several novel nosographic entities, such as thrombocytopenias deriving from mutations in CYCS, TUBB1, FLNA, ITGA2B/ITGB3, ANKRD26 and ACTN1.
|
23636669 |
2014 |
Thrombocytopenia
|
0.440 |
GeneticVariation
|
phenotype |
BEFREE |
THC4 is an autosomal dominant mild thrombocytopenia described in only one large family from New Zealand and due to a mutation (G41S) of the somatic isoform of the cytochrome c (CYCS) gene.
|
24326104 |
2014 |
Thrombocytopenia
|
0.440 |
GeneticVariation
|
phenotype |
LHGDN |
In 77 Italian patients with inherited thrombocytopenia and clinical and laboratory features similar to those of patients with the CYCS missense (Gly41Ser) mutation, no alterations of the open reading frame were identified.
|
19172527 |
2009 |
Thrombocytopenia
|
0.440 |
Biomarker
|
phenotype |
CTD_human |
A mutation of human cytochrome c enhances the intrinsic apoptotic pathway but causes only thrombocytopenia.
|
18345000 |
2008 |
Thrombocytopenia
|
0.440 |
GeneticVariation
|
phenotype |
LHGDN |
Mutation of human cytochrome c enhances the intrinsic apoptotic pathway and causes thrombocytopenia
|
18345000 |
2008 |
Thrombocytopenia
|
0.440 |
Biomarker
|
phenotype |
HPO |
|
|
|
Cytopenia
|
0.300 |
Biomarker
|
phenotype |
GENOMICS_ENGLAND |
Mutations of cytochrome c identified in patients with thrombocytopenia THC4 affect both apoptosis and cellular bioenergetics.
|
24326104 |
2014 |
Congenital anemia
|
0.300 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Mutations of cytochrome c identified in patients with thrombocytopenia THC4 affect both apoptosis and cellular bioenergetics.
|
24326104 |
2014 |
Mitochondrial Diseases
|
0.300 |
Biomarker
|
group |
GENOMICS_ENGLAND |
Mutations of cytochrome c identified in patients with thrombocytopenia THC4 affect both apoptosis and cellular bioenergetics.
|
24326104 |
2014 |
Cytopenia
|
0.300 |
Biomarker
|
phenotype |
GENOMICS_ENGLAND |
A mutation of human cytochrome c enhances the intrinsic apoptotic pathway but causes only thrombocytopenia.
|
18345000 |
2008 |
Congenital anemia
|
0.300 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
A mutation of human cytochrome c enhances the intrinsic apoptotic pathway but causes only thrombocytopenia.
|
18345000 |
2008 |
Mitochondrial Diseases
|
0.300 |
Biomarker
|
group |
GENOMICS_ENGLAND |
A mutation of human cytochrome c enhances the intrinsic apoptotic pathway but causes only thrombocytopenia.
|
18345000 |
2008 |
Chloracne
|
0.300 |
Biomarker
|
disease |
CTD_human |
Microarray analysis of gene expression in peripheral blood mononuclear cells from dioxin-exposed human subjects.
|
17101203 |
2007 |
Methylmalonic acidemia
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
Quantitative analysis of mitochondrial protein expression in methylmalonic acidemia by two-dimensional difference gel electrophoresis.
|
16823967 |
2006 |
Methylmalonic aciduria
|
0.300 |
Biomarker
|
disease |
CTD_human |
Quantitative analysis of mitochondrial protein expression in methylmalonic acidemia by two-dimensional difference gel electrophoresis.
|
16823967 |
2006 |
Obesity
|
0.300 |
Biomarker
|
disease |
CTD_human |
Alcohol increases tumor necrosis factor alpha and decreases nuclear factor-kappab to activate hepatic apoptosis in genetically obese mice.
|
16317704 |
2005 |
Ischemia
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
Minocycline inhibits apoptosis and inflammation in a rat model of ischemic renal injury.
|
15172883 |
2004 |
Brain Ischemia
|
0.300 |
Biomarker
|
disease |
CTD_human |
Overexpression of copper/zinc superoxide dismutase in transgenic rats protects vulnerable neurons against ischemic damage by blocking the mitochondrial pathway of caspase activation.
|
11756504 |
2002 |
Cerebral Ischemia
|
0.300 |
Biomarker
|
disease |
CTD_human |
Overexpression of copper/zinc superoxide dismutase in transgenic rats protects vulnerable neurons against ischemic damage by blocking the mitochondrial pathway of caspase activation.
|
11756504 |
2002 |
Transient Ischemic Attack
|
0.300 |
Biomarker
|
disease |
CTD_human |
Manganese Superoxide Dismutase Affects Cytochrome c Release and Caspase-9 Activation After Transient Focal Cerebral Ischemia in Mice.
|
11333366 |
2001 |